Meta-analysis and GRADE Evidence Evaluation on the Intervention of Oral Chinese Patent Medicine in Coronary Slow Flow PhenomenonCHEN Jiaping, SHANG Yu, LIU Hongxu, LAI Xiaolei, LI Xiang, SHANG Juju, ZHOU Huiwen801-811
The Mechanism of Modified Gualou Xiebai Banxia Decoction for Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking TechnologyMA Wenhao, CHEN Kaijie, LI Tong, GU Yonggang, GU Xuefeng812-821
The Value of Ratio of Hypersensitive C-reactive Protein to Prealbumin and Tei Index in Evaluating Volume Load in Patients with Acute Decompensated Heart FailureYANG Geng822-829
Effects of Yiqitongluo Formula on Endothelial Cells and Inflammatory Factors in Patients with Coronary Microvascular DiseaseXIE Fengqun, ZHU Wen, CHENG Jie, FENG Qimao830-835
Prognostic Value of Serum LncRNA ZFAS1 and LncRNA TUG1 for Prognosis in Elderly Patients with Chronic Heart FailureLIU Xiaolin, MA Wenhui, ZHANG Yujie, YU Huapeng, MA Shengting836-840
The Mechanisms of Astragalus Polysaccharide for Protecting Cardiomyocytes against H2O2-induced ApoptosisWU Shengjie, WAN Siyuan, WANG Zhewen, YANG Shiyu, WANG Yihui, GUO Haidong, LI Han841-847
The Improvement of Myocardial Energy Metabolism by Regulating Mitochondrial Function of Shexiang Baoxin Pills Based on AMPK/PGC-1α PathwaySONG Xiaolong, PAN Renyou, GU Yuexing, SONG Jun, TU Dongyun, WU Deming, NI Qimeng848-856
Protective Effect of Tongmai Jiangtang Formula on Hyperglycaemic Cardiomyocytes form Hypoxia/Reoxygenation Induced-injury by Regulating Nrf2-GSH-GPX4-mediated Ferroptosis PathwayLIU Yuzhe, YE Pan, LIU Ping, LI Xiuqing857-862
The Mechanism of Astragaloside on Myocardium Injury in Rats of Hypoxic-induced Heart Failure Based on HIFs/RhoB/ROCK PathwayZHANG Jia, QIN Rui, LI Gang863-868
Review of Volume Management and Application of Traditional Chinese Medicine in Refractory Heart FailureZHOU Lin, GE Zhao, WANG Xianliang869-872
